{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:07:06Z","timestamp":1743739626200,"version":"3.40.3"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Psychedelic drugs, known for their perception-altering properties, are gaining popularity in the treatment of mental health and pain disorders. As exploratory studies demonstrate clinical efficacy with few adverse events, it is expected that more patients will ingest psychedelic drugs. For therapeutic reasons, as with any drug, anaesthesiologists must be aware of its physiological effects and contraindications to ensure the safe provision of anaesthesia.<\/jats:p>\n            <jats:p>Psilocybin is a 5HT<jats:sub>1A<\/jats:sub> and 5HT<jats:sub>2A<\/jats:sub> serotonin receptor agonist thought to act on excitatory and inhibitory neurons in the brain. Acute ingestion causes sympathetic nervous system activation, which can precipitate haemodynamic instability. Activation of the 5HT serotonin receptors can also place the patient at risk of serotonin syndrome. Chronic use increases plasma concentrations of cortisol, which has implications on prophylactic stress-dosing of glucocorticoids preoperatively. Lysergic acid diethylamide (LSD), a synthetic psychoactive substance, is also a 5HT2<jats:sub>A<\/jats:sub> agonist. LSD has been shown to potentiate opioid analgesics, and monoamine oxidase (MAO) inhibition. Historical reports suggest that LSD has anticholinesterase activity and can prolong neuromuscular block with depolarising muscle relaxants. Mescaline is a poorly understood psychedelic with similar autonomic effects. Historical studies have shown decreased neuromuscular transmission and an association with malignant hyperthermia.<\/jats:p>\n            <jats:p>When managing patients who have consumed psychedelics drugs, it is important to consider delaying surgery whenever possible, to allow acute intoxication to wane. A high degree of suspicion and an understanding of management principles is vital to the safe conduct of anaesthesia. Future research should explore therapeutic doses of psychedelic drugs to understand physiologic effects at various concentrations.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/eja.0000000000002138","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:01:06Z","timestamp":1739955666000},"page":"430-434","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new"],"prefix":"10.1097","volume":"42","author":[{"given":"Mansi","family":"Dave","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Cupido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Haley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-714X","authenticated-orcid":false,"given":"David","family":"Clinkard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"R1-20250402","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/papr.13203","article-title":"Are psychedelics the answer to chronic pain: a review of current literature","volume":"23","author":"Kooijman","year":"2023","journal-title":"Pain Pract"},{"key":"R2-20250402","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/molecules26102948","article-title":"Psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"R3-20250402","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12916-024-03370-7","article-title":"Canadians\u2019 use of cannabis for therapeutic purposes since legalisation of recreational cannabis: a cross-sectional analysis by medical authorisation status","volume":"22","author":"Balneaves","year":"2024","journal-title":"BMC Med"},{"key":"R4-20250402","doi-asserted-by":"crossref","first-page":"n2040","DOI":"10.1136\/bmj.n2040","article-title":"Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline","volume":"374","author":"Busse","year":"2021","journal-title":"BMJ"},{"key":"R7-20250402","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/j.pain.0000000000002778","article-title":"Microdosing psilocybin for chronic pain: a case series","volume":"164","author":"Lyes","year":"2023","journal-title":"Pain"},{"key":"R8-20250402","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.suc.2014.11.001","article-title":"Perioperative management in the patient with substance abuse","volume":"95","author":"Moran","year":"2015","journal-title":"Surg Clin North Am"},{"key":"R9-20250402","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ijnp\/pyac074","article-title":"Default mode network modulation by psychedelics: a systematic review","volume":"26","author":"Gattuso","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"key":"R10-20250402","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.4123-07.2008","article-title":"Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics","volume":"28","author":"Baliki","year":"2008","journal-title":"J Neurosci"},{"key":"R11-20250402","doi-asserted-by":"crossref","first-page":"1040217","DOI":"10.3389\/fpsyt.2022.1040217","article-title":"Therapeutic use of psilocybin: practical considerations for dosing and administration","volume":"13","author":"MacCallum","year":"2022","journal-title":"Front Psychiatry"},{"key":"R12-20250402","doi-asserted-by":"crossref","first-page":"24","DOI":"10.9740\/mhc.2017.01.024","article-title":"Clinical potential of psilocybin as a treatment for mental health conditions","volume":"7","author":"Daniel","year":"2018","journal-title":"Ment Health Clin"},{"key":"R13-20250402","doi-asserted-by":"crossref","first-page":"113638","DOI":"10.1016\/j.expneurol.2021.113638","article-title":"New psychoactive substances (NPS) and serotonin syndrome onset: a systematic review","volume":"339","author":"Schifano","year":"2021","journal-title":"Exp Neurol"},{"key":"R14-20250402","doi-asserted-by":"crossref","first-page":"1214969","DOI":"10.3389\/fneur.2023.1214969","article-title":"Case report: psychedelic-induced seizures captured by intracranial electrocorticography","volume":"14","author":"Blond","year":"2023","journal-title":"Front Neurol"},{"key":"R15-20250402","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12016-013-8370-2","article-title":"Alternative drugs of abuse","volume":"46","author":"Sutter","year":"2014","journal-title":"Clinic Rev Allerg Immunol"},{"key":"R16-20250402","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/chem.201904363","article-title":"Simultaneous production of psilocybin and a cocktail of \u03b2-carboline monoamine oxidase inhibitors in \u2018magic\u2019 mushrooms","volume":"26","author":"Blei","year":"2020","journal-title":"Chemistry"},{"key":"R17-20250402","first-page":"457","article-title":"Pharmacological action of LSD: LSD effect on the neurotransmission and animal behavior","author":"Herian","year":"2022","journal-title":"Handbook of substance misuse and addictions"},{"key":"R19-20250402","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"R20-20250402","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/add.16518","article-title":"A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia","volume":"119","author":"Darke","year":"2024","journal-title":"Addiction"},{"key":"R21-20250402","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0024-3205(98)00262-8","article-title":"Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro","volume":"63","author":"Giacomelli","year":"1998","journal-title":"Life Sci"},{"key":"R22-20250402","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol Psychiatry"},{"key":"R23-20250402","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/npp.2017.86","article-title":"Modern clinical research on LSD","volume":"42","author":"Liechti","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"R24-20250402","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-4159.1963.tb09483.x","article-title":"The effect of lysergic acid diethylamide on the acetylcholinesterase activity of single nerve cells from the reticular formation","volume":"10","author":"Pavlin","year":"1963","journal-title":"J Neurochem"},{"key":"R25-20250402","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/bcp.13578","article-title":"Can H2 -receptor upregulation and raised histamine explain an anaphylactoid reaction on cessation of ranitidine in a 19-year-old female? A case report","volume":"84","author":"Allen","year":"2018","journal-title":"Brit J Clin Pharma"},{"key":"R26-20250402","doi-asserted-by":"crossref","first-page":"109294","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: the forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"key":"R27-20250402","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"R28-20250402","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0028-3908(93)90097-M","article-title":"Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission","volume":"32","author":"Ghansah","year":"1993","journal-title":"Neuropharmacology"},{"key":"R29-20250402","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00171727","article-title":"Pharmacodynamic effects of serotonin (5-ht) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia","volume":"341","author":"L\u00f6scher","year":"1990","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T11:06:13Z","timestamp":1743678373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002138"}},"subtitle":["A narrative review on psychedelics and anaesthesia"],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000002138","relation":{},"ISSN":["0265-0215","1365-2346"],"issn-type":[{"type":"print","value":"0265-0215"},{"type":"electronic","value":"1365-2346"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"2024-06-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}